These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2225482)

  • 1. The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in north Canterbury, 1983-1985.
    Brownlie BE; Wells JE
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):249-59. PubMed ID: 2225482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreasing incidence of thyrotoxicosis in an endemic goitre inland area of Sweden.
    Lundgren E; Borup Christensen S
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):133-8. PubMed ID: 2401093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmö 1970-74.
    Berglund J; Christensen SB; Hallengren B
    J Intern Med; 1990 Feb; 227(2):137-41. PubMed ID: 2299305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iodine deficiency disorder persistance after introduction of iodized salt in a previously endemic goiter area].
    Isidro San Juan ML; Vidal Casariego A; Argueso Armesto A; Alvarez Castro P; Vidal Pardo JI; Cordido Carballido F
    An Med Interna; 2004 Apr; 21(4):171-4. PubMed ID: 15109284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma.
    Lantz M; Abraham-Nordling M; Svensson J; Wallin G; Hallengren B
    Eur J Endocrinol; 2009 Feb; 160(2):201-6. PubMed ID: 19004985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland.
    Laurberg P; Pedersen KM; Vestergaard H; Sigurdsson G
    J Intern Med; 1991 May; 229(5):415-20. PubMed ID: 2040867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current incidence of thyrotoxicosis and past prevalence of goitre in 12 British towns.
    Barker DJ; Phillips DI
    Lancet; 1984 Sep; 2(8402):567-70. PubMed ID: 6147612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychoses associated with thyrotoxicosis - 'thyrotoxic psychosis.' A report of 18 cases, with statistical analysis of incidence.
    Brownlie BE; Rae AM; Walshe JW; Wells JE
    Eur J Endocrinol; 2000 May; 142(5):438-44. PubMed ID: 10802519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotoxicosis in Nigeria. Analysis of a five year experience.
    Famuyiwa OO; Bella AF
    Trop Geogr Med; 1990 Jul; 42(3):248-54. PubMed ID: 1705731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxic nodular goiter].
    Sarr A; Ndour MM; Diop SN; Ka CM; Dieng P; Diedhiou D; Sidibé EH; Sow AM
    Dakar Med; 2007; 52(2):135-40. PubMed ID: 19102108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile thyrotoxicosis--a South Island, New Zealand experience with long-term outcome.
    Brownlie BE; Hunt PJ; Turner JG
    N Z Med J; 2010 Apr; 123(1313):23-31. PubMed ID: 20581892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The geographical distribution of thyrotoxicosis in England according to the presence or absence of TSH-receptor antibodies.
    Phillips DI; Barker DJ; Rees Smith B; Didcote S; Morgan D
    Clin Endocrinol (Oxf); 1985 Sep; 23(3):283-7. PubMed ID: 3000650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Different etiology of thyrotoxicosis as a function of previous prevalence of goiter].
    Cordido F; Vidal JI; Valiño D; Tuñez F; Maíz D; Jorge S; Vidal O
    Med Clin (Barc); 1992 Jun; 99(5):175-8. PubMed ID: 1507896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management.
    Díez JJ
    Gerontology; 2003; 49(5):316-23. PubMed ID: 12920352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High risk of thyrotoxicosis in Northern Sweden. Retrospective survey of medical records for 2004-2005 in Norrbothnia].
    Westerlund E; Eliasson M
    Lakartidningen; 2008 Nov 5-11; 105(45):3196-201. PubMed ID: 19062611
    [No Abstract]   [Full Text] [Related]  

  • 16. A long-term follow-up study of patients with non-toxic diffuse goitre in Japan.
    Hara T; Tamai H; Mukuta T; Fukata S; Kuma K; Nakagawa T
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):541-6. PubMed ID: 8252742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic multinodular goitre in a patient with generalized resistance to thyroid hormone who harbours the R429Q mutation in the thyroid hormone receptor beta gene.
    Taniyama M; Ishikawa N; Momotani N; Ito K; Ban Y
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):121-4. PubMed ID: 11167935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence.
    Barclay ML; Brownlie BE; Turner JG; Wells JE
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):759-64. PubMed ID: 8033366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of thyrotoxicosis in Malmö during the years 1988-1990 as compared to the years 1970-1974.
    Berglund J; Ericsson UB; Hallengren B
    J Intern Med; 1996 Jan; 239(1):57-62. PubMed ID: 8551201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytophotometric determination of nuclear size and DNA distribution in different hyperfunctioning thyroid lesions.
    Bjelkenkrantz K; Risberg B; Eneström S; Stål O
    Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):129-37. PubMed ID: 6819706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.